Comprehensive Diagnostic & Therapeutic Reference Profile
Also known as: PTSD, Post-Traumatic Stress Syndrome, Shell Shock, Combat Fatigue
Post-Traumatic Stress Disorder (PTSD) is a complex psychiatric condition triggered by witnessing or experiencing a terrifying event. It is characterized by persistent intrusive thoughts, avoidance behaviors, negative alterations in cognition and mood, and heightened physiological reactivity that persist for more than one month, significantly impairing functional capacity.
The etiology is multifactorial, involving an interaction between environmental trauma (e.g., combat, assault, disasters) and individual vulnerability. Genetic predisposition accounts for approximately 30-40% of variance in susceptibility. Epigenetic modifications, particularly in the hypothalamic-pituitary-adrenal (HPA) axis regulation, play a critical role.
PTSD involves dysregulation of the HPA axis, resulting in abnormal cortisol levels. Neuroanatomical studies indicate hyper-responsiveness of the amygdala, hypo-responsiveness of the medial prefrontal cortex (mPFC), and reduced hippocampal volume. These changes impair the brain's ability to regulate emotional responses and contextualize memories, leading to the "stuck" state of fear.
Global lifetime prevalence is estimated at 6-8%. Women are twice as likely to develop PTSD as men. Onset can occur at any age, though it is most frequently diagnosed in early to middle adulthood.
History of childhood trauma, lack of social support, personal or family history of mental illness, intensity/proximity of the trauma, and low socioeconomic status.
A. Early Symptoms
Generally unremarkable. Findings may include autonomic nervous system arousal (tachycardia, diaphoresis) during triggering events or somatic complaints such as hypertension, gastrointestinal distress, or musculoskeletal tension.
A. Clinical Assessment: Structured clinical interviews (e.g., CAPS-5) and self-report scales (PCL-5).
B. Laboratory Testing: None specific; used to rule out medical mimics.
C. Imaging Studies: Research tool; not standard for diagnosis.
D. Functional Tests: Not applicable.
E. Biopsy Findings: Not applicable.
F. Genetic Testing: Experimental.
G. Differential Diagnosis: Major Depressive Disorder, Panic Disorder, Adjustment Disorder.
Test Name: Toxicology Screen
Type: Urine Test
Purpose: Rule out substance-induced psychiatric symptoms.
Expected Findings: Negative for stimulants/hallucinogens.
Interpretation: Negative results support PTSD diagnosis over substance abuse.
Purpose: Structural MRI. Typical Findings: Reduced hippocampal volume. Clinical Importance: Primarily research-based; used occasionally to exclude organic brain injury.
Acute Stress Disorder (duration <1 month), Traumatic Brain Injury (TBI), and Borderline Personality Disorder.
Major Depressive Disorder, substance use disorder, cardiovascular disease, chronic pain, and social/occupational dysfunction.
A. Lifestyle Modifications: Sleep hygiene, mindfulness, physical exercise.
B. Preventive Measures: Psychological first aid post-trauma.
C. Medical Treatment
| Drug Class | Mechanism | Examples |
| :--- | :--- | :--- |
| SSRIs | Serotonin Reuptake Inhibition | Sertraline, Paroxetine |
| Alpha-1 Blockers | Noradrenergic inhibition | Prazosin (for nightmares) | D. Surgical Treatment: N/A
E. Interventional Procedures: Stellate Ganglion Block (SGB) (investigational).
F. Rehabilitation: Cognitive Processing Therapy (CPT), EMDR.
G. Emergency Management: Crisis intervention, hospitalization for safety.
Variable; some recover within months with therapy, others experience a chronic course requiring long-term pharmacological support.
Early interventions (e.g., Trauma-Focused CBT) for those exposed to severe trauma can reduce the incidence of full-blown PTSD.
The following homeopathic remedies have been historically indicated for symptoms associated with Post-Traumatic Stress Disorder. Selection should be based on individualized symptom totality and constitutional assessment.
This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.
Evaluates chronic stress-induced adrenal exhaustion, cortisol pattern variations, and systemic fatigue characteristics.
Evaluates chronic stress-induced adrenal exhaustion, cortisol pattern variations, and systemic fatigue characteristics.
Evaluates chronic stress-induced adrenal exhaustion, cortisol pattern variations, and systemic fatigue characteristics.
🚀 Open Calculator PageSpeak with our specialists for a customized treatment protocol for this condition.
📅 Request ConsultationThis clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.